Seres Therapeutics Inc. (MCRB) NASDAQ
$0.93 (0.03) (-3.28%)
Market Cap: $145.07M
As of 05/16/24 09:50 AM EDT. Market open.
Seres Therapeutics Inc. (MCRB)
NASDAQ
$0.93
(0.03) (-3.28%)
Market Cap: $145.07M
As of 05/16/24 09:50 AM EDT. Market open.
Add to Portfolio
seres therapeutics is a clinical stage biotherapeutic company focused on discovering and developing ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. founded by flagship venturelabs, seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. current ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Eric Shaff
Full Time Employees
486
CEO Compensation (Base)
$595,000
CEO Compensation (Total)
$3.02M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Eric Shaff
Full Time Employees
486
CEO Compensation (Base)
$595,000
CEO Compensation (Total)
$3.02M
Address
200 Sidney St, Massachusetts, Cambridge, 02139-4218.
PRICE CHART FOR SERES THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.97
Previous Close
$0.96
Days Range
$0.91 - $1.03
52 week range
$0.54 - $6.26
Volume
509,935
Avg. Volume (30 days)
6,419,203
Market Cap
$145.07M
Dividend Yield
-
P/E
(1.75)
Shares Outstanding
151,447,763
Open
$0.97
Previous Close
$0.96
Days Range
$0.91 - $1.03
52 week range
$0.54 - $6.26
Volume
509,935
Avg. Volume (30 days)
6,419,203
Market Cap
$145.07M
Dividend Yield
-
P/E
(1.75)
Shares Outstanding
151,447,763
FINANCIAL STATEMENTS FOR SERES THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SERES THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| DesRosier Thomas | Chief Legal Officer and EVP | Feb 16, 2024 | Sale | $1.08 | 3,939 | 4,254 | 120,577 | Feb 16, 2024, 09:48 PM |
| Shaff Eric D. | CEO and President | Feb 16, 2024 | Sale | $1.08 | 11,549 | 12,473 | 135,321 | Feb 16, 2024, 09:42 PM |
| Henn Matthew R. | See Remarks | Feb 16, 2024 | Sale | $1.08 | 4,170 | 4,504 | 63,436 | Feb 16, 2024, 09:31 PM |
| Young Teresa L. | See Remarks | Feb 16, 2024 | Sale | $1.08 | 3,374 | 3,644 | 15,705 | Feb 16, 2024, 09:29 PM |
| von Moltke Lisa | See Remarks | Feb 16, 2024 | Sale | $1.08 | 4,400 | 4,752 | 16,988 | Feb 16, 2024, 09:21 PM |
| Ege David S. | See Remarks | Feb 16, 2024 | Sale | $1.08 | 5,010 | 5,411 | 73,856 | Feb 16, 2024, 09:15 PM |
| Arkowitz David | Chief Financial Officer | Feb 16, 2024 | Sale | $1.08 | 3,939 | 4,254 | 182,442 | Feb 16, 2024, 09:13 PM |
| Cloghessy Paula | See Remarks | Oct 30, 2023 | Sale | $1.35 | 2,904 | 3,920 | 45,684 | Oct 31, 2023, 09:43 PM |
| Shaff Eric D. | CEO and President | Oct 30, 2023 | Sale | $1.35 | 8,552 | 11,545 | 115,620 | Oct 31, 2023, 09:40 PM |
| Young Teresa L. | See Remarks | Oct 30, 2023 | Sale | $1.35 | 2,907 | 3,924 | 8,454 | Oct 31, 2023, 09:40 PM |
| Arkowitz David | Chief Financial Officer | Oct 30, 2023 | Sale | $1.35 | 4,066 | 5,489 | 175,756 | Oct 31, 2023, 09:39 PM |
| DesRosier Thomas | Chief Legal Officer and EVP | Oct 30, 2023 | Sale | $1.35 | 4,156 | 5,611 | 113,891 | Oct 31, 2023, 09:39 PM |
| Ege David S. | See Remarks | Oct 30, 2023 | Sale | $1.35 | 4,066 | 5,489 | 66,991 | Oct 31, 2023, 09:39 PM |
| von Moltke Lisa | See Remarks | Oct 30, 2023 | Sale | $1.35 | 4,232 | 5,713 | 9,513 | Oct 31, 2023, 09:36 PM |
| Henn Matthew R. | See Remarks | Oct 30, 2023 | Sale | $1.35 | 3,886 | 5,246 | 56,356 | Oct 31, 2023, 09:36 PM |
| Ege David S. | See Remarks | Apr 28, 2023 | Sale | $5.19 | 7,038 | 36,527 | 59,696 | May 01, 2023, 04:46 PM |
| Ege David S. | See Remarks | Oct 31, 2022 | Sale | $7.93 | 5,012 | 39,745 | 46,734 | Oct 31, 2022, 07:37 PM |
| Nutritional Health LTP Fund General Partner LLC | 10% Owner | Jul 05, 2022 | Buy | $3.15 | 5,825,495 | 18,350,310 | 5,825,495 | Jul 07, 2022, 05:00 PM |
| Nutritional Health LTP Fund General Partner LLC | 10% Owner | Jul 05, 2022 | Buy | $3.15 | 2,912,748 | 9,175,156 | 5,875,711 | Jul 07, 2022, 05:00 PM |
| DesRosier Thomas | Chief Legal Officer and EVP | Jul 05, 2022 | Option Exercise | $3.15 | 63,492 | 200,000 | 104,546 | Jul 06, 2022, 07:29 PM |
| Henn Matthew R. | See Remarks | Jul 05, 2022 | Option Exercise | $3.15 | 47,619 | 150,000 | 47,619 | Jul 06, 2022, 07:27 PM |
| Cloghessy Paula | See Remarks | Jul 05, 2022 | Option Exercise | $3.15 | 31,746 | 100,000 | 31,746 | Jul 06, 2022, 07:25 PM |
| Arkowitz David | Chief Financial Officer | Jul 05, 2022 | Option Exercise | $3.15 | 63,492 | 200,000 | 65,492 | Jul 06, 2022, 07:23 PM |
| Kender Richard N | Director | Jul 05, 2022 | Option Exercise | $3.15 | 63,492 | 200,000 | 63,492 | Jul 06, 2022, 07:23 PM |
| Ege David S. | See Remarks | Jul 05, 2022 | Option Exercise | $3.15 | 31,746 | 100,000 | 31,746 | Jul 06, 2022, 07:22 PM |
| Dere Willard H | Director | Jul 05, 2022 | Option Exercise | $3.15 | 31,746 | 100,000 | 31,746 | Jul 06, 2022, 07:22 PM |
| Shaff Eric D. | CEO and President | Jul 05, 2022 | Option Exercise | $3.15 | 63,492 | 200,000 | 96,334 | Jul 06, 2022, 07:21 PM |
| Zausner Meryl | Director | Jul 05, 2022 | Option Exercise | $3.15 | 31,746 | 100,000 | 31,746 | Jul 06, 2022, 07:19 PM |
| Biondi Paul | Director | Jul 05, 2022 | Option Exercise | $3.15 | 47,619 | 150,000 | 47,619 | Jul 06, 2022, 07:19 PM |
| Henn Matthew R. | See Remarks | Dec 01, 2020 | Option Exercise | $5.56 | 79,812 | 443,720 | 91,812 | Dec 03, 2020, 04:05 PM |
| Henn Matthew R. | See Remarks | Dec 01, 2020 | Sale | $27.04 | 91,812 | 2,482,309 | 36,106 | Dec 03, 2020, 04:05 PM |
| Chapman Marcus | See Remarks | Nov 22, 2019 | Sale | $3.91 | 3,400 | 13,297 | 8,600 | Nov 25, 2019, 04:32 PM |
| AFEYAN NOUBAR | Director | Jun 18, 2019 | Buy | $2.25 | 8,888,888 | 19,999,998 | 4,444,444 | Jun 20, 2019, 04:17 PM |
| DesRosier Thomas | Chief Legal Officer and EVP | Jan 28, 2019 | Sale | $5.75 | 5,471 | 31,478 | 16,054 | Jan 29, 2019, 06:55 PM |
| Shaff Eric D. | See Remarks | Jan 28, 2019 | Sale | $5.75 | 4,378 | 25,188 | 12,842 | Jan 29, 2019, 06:52 PM |
| Aunins John G. | Chief Technology Officer & EVP | Dec 17, 2018 | Sale | $6.39 | 14,282 | 91,313 | 75,250 | Dec 19, 2018, 04:11 PM |
| Aunins John G. | See Remarks | Nov 15, 2018 | Sale | $8.26 | 14,279 | 117,912 | 89,532 | Nov 19, 2018, 04:27 PM |
| Aunins John G. | See Remarks | Oct 15, 2018 | Sale | $5.94 | 14,279 | 84,800 | 103,811 | Oct 16, 2018, 04:16 PM |
| Aunins John G. | See Remarks | Aug 15, 2018 | Sale | $7.57 | 14,279 | 108,069 | 132,369 | Sep 19, 2018, 09:22 PM |
| Aunins John G. | See Remarks | May 15, 2018 | Sale | $8.08 | 14,279 | 115,400 | 146,648 | Sep 19, 2018, 09:22 PM |
| Aunins John G. | See Remarks | Sep 17, 2018 | Sale | $7.27 | 14,279 | 103,875 | 118,090 | Sep 19, 2018, 09:22 PM |
| Pomerantz Roger | President and CEO | Sep 06, 2018 | Sale | $9.04 | 3,013 | 27,235 | 215,786 | Sep 06, 2018, 05:08 PM |
| Pomerantz Roger | President and CEO | Sep 05, 2018 | Sale | $9.12 | 9,505 | 86,714 | 218,799 | Sep 06, 2018, 05:08 PM |
| Aunins John G. | Chief Technology Officer & EVP | Jul 15, 2018 | Sale | $8.10 | 14,279 | 115,726 | 160,927 | Jul 18, 2018, 04:58 PM |
| Pomerantz Roger | President and CEO | Jul 11, 2018 | Option Exercise | $0.71 | 1,010 | 717 | 229,314 | Jul 12, 2018, 05:15 PM |
| Pomerantz Roger | President and CEO | Jul 11, 2018 | Sale | $9.01 | 1,010 | 9,099 | 228,304 | Jul 12, 2018, 05:15 PM |
| Pomerantz Roger | President and CEO | Jul 10, 2018 | Option Exercise | $0.71 | 5,989 | 4,252 | 234,293 | Jul 10, 2018, 05:49 PM |
| Pomerantz Roger | President and CEO | Jul 09, 2018 | Option Exercise | $0.71 | 10,981 | 7,797 | 239,285 | Jul 10, 2018, 05:49 PM |
| Pomerantz Roger | President and CEO | Jul 06, 2018 | Option Exercise | $0.71 | 15,366 | 10,910 | 243,670 | Jul 10, 2018, 05:49 PM |
| Pomerantz Roger | President and CEO | Jul 10, 2018 | Sale | $9.05 | 5,989 | 54,208 | 228,304 | Jul 10, 2018, 05:49 PM |
| Pomerantz Roger | President and CEO | Jul 09, 2018 | Sale | $9.14 | 10,981 | 100,351 | 228,304 | Jul 10, 2018, 05:49 PM |
| Pomerantz Roger | President and CEO | Jul 06, 2018 | Sale | $9.14 | 15,366 | 140,507 | 228,304 | Jul 10, 2018, 05:49 PM |
| Pomerantz Roger | President and CEO | Jun 29, 2018 | Option Exercise | $0.71 | 4,496 | 3,192 | 232,800 | Jun 29, 2018, 05:12 PM |
| Pomerantz Roger | President and CEO | Jun 28, 2018 | Option Exercise | $0.71 | 21,560 | 15,308 | 249,864 | Jun 29, 2018, 05:12 PM |
| Pomerantz Roger | President and CEO | Jun 29, 2018 | Sale | $9.10 | 4,496 | 40,915 | 228,304 | Jun 29, 2018, 05:12 PM |
| Pomerantz Roger | President and CEO | Jun 28, 2018 | Sale | $9.15 | 21,560 | 197,375 | 228,304 | Jun 29, 2018, 05:12 PM |
| Pomerantz Roger | President and CEO | Jun 26, 2018 | Option Exercise | $0.71 | 21,224 | 15,069 | 249,528 | Jun 27, 2018, 09:06 PM |
| Pomerantz Roger | President and CEO | Jun 25, 2018 | Option Exercise | $0.71 | 16,288 | 11,564 | 255,056 | Jun 27, 2018, 09:06 PM |
| Pomerantz Roger | President and CEO | Jun 27, 2018 | Option Exercise | $0.71 | 16,991 | 12,064 | 245,295 | Jun 27, 2018, 09:06 PM |
| Pomerantz Roger | President and CEO | Jun 26, 2018 | Sale | $9.19 | 21,224 | 195,133 | 228,304 | Jun 27, 2018, 09:06 PM |
| Pomerantz Roger | President and CEO | Jun 25, 2018 | Sale | $9.21 | 26,752 | 246,504 | 228,304 | Jun 27, 2018, 09:06 PM |
| Pomerantz Roger | President and CEO | Jun 27, 2018 | Sale | $9.03 | 16,991 | 153,408 | 228,304 | Jun 27, 2018, 09:06 PM |
| Pomerantz Roger | President and CEO | Jun 22, 2018 | Sale | $9.36 | 40,057 | 374,761 | 238,768 | Jun 22, 2018, 09:11 PM |
| Pomerantz Roger | President and CEO | Jun 21, 2018 | Sale | $9.06 | 18,987 | 172,094 | 278,825 | Jun 22, 2018, 09:11 PM |
| Pomerantz Roger | President and CEO | Jun 20, 2018 | Sale | $9.33 | 26,492 | 247,051 | 297,812 | Jun 22, 2018, 09:11 PM |
| Aunins John G. | Chief Technology Officer & EVP | Jun 15, 2018 | Sale | $8.57 | 14,279 | 122,325 | 170,206 | Jun 18, 2018, 04:43 PM |
| Pomerantz Roger | President and CEO | May 09, 2018 | Sale | $9.00 | 233 | 2,097 | 324,304 | May 10, 2018, 04:44 PM |
| Aunins John G. | Chief Technology Officer & EVP | Apr 25, 2018 | Sale | $7.58 | 14,279 | 108,266 | 184,485 | Apr 26, 2018, 04:55 PM |
| Aunins John G. | See Remarks | Jan 26, 2018 | Sale | $11.02 | 1,738 | 19,153 | 198,764 | Jan 30, 2018, 09:01 PM |
| Shaff Eric D. | See Remarks | Jan 26, 2018 | Sale | $11.02 | 2,780 | 30,636 | 5,220 | Jan 30, 2018, 09:01 PM |
| DesRosier Thomas | See Remarks | Jan 26, 2018 | Sale | $11.02 | 3,475 | 38,295 | 6,525 | Jan 30, 2018, 08:58 PM |
| Trucksis Michele | See Remarks | Jan 26, 2018 | Sale | $11.02 | 2,607 | 28,729 | 4,893 | Jan 30, 2018, 08:58 PM |
| COOK DAVID N | See Remarks | Jan 26, 2018 | Sale | $11.02 | 1,738 | 19,153 | 139,935 | Jan 30, 2018, 08:58 PM |
| Aunins John G. | See Remarks | Dec 19, 2017 | Sale | $10.14 | 1,623 | 16,457 | 195,502 | Jan 30, 2018, 08:54 PM |
| Pomerantz Roger | President and CEO | Jan 24, 2018 | Option Exercise | $0.71 | 40,241 | 28,571 | 324,537 | Jan 25, 2018, 04:39 PM |
| Aunins John G. | Chief Technology Officer & EVP | Dec 19, 2017 | Sale | $10.14 | 1,623 | 16,457 | 59,437 | Dec 20, 2017, 04:56 PM |
| Pomerantz Roger | President and CEO | Jul 18, 2017 | Option Exercise | $0.71 | 100,604 | 71,429 | 284,296 | Jul 20, 2017, 04:36 PM |
| Aunins John G. | Chief Technology Officer & EVP | Apr 25, 2016 | Sale | $31.94 | 18,640 | 595,362 | 56,060 | Aug 31, 2016, 08:47 PM |
| Aunins John G. | Chief Technology Officer & EVP | Aug 29, 2016 | Sale | $10.87 | 9,390 | 102,069 | 192,125 | Aug 30, 2016, 07:23 PM |
| Aunins John G. | Chief Technology Officer & EVP | Jul 27, 2016 | Sale | $35.00 | 9,250 | 323,750 | 201,515 | Jul 29, 2016, 04:50 PM |
| Trucksis Michele | Chief Medical Officer and EVP | Jul 28, 2016 | Option Exercise | $15.77 | 4,156 | 65,540 | 4,156 | Jul 29, 2016, 04:49 PM |
| Trucksis Michele | Chief Medical Officer and EVP | Jul 28, 2016 | Sale | $35.18 | 4,156 | 146,207 | 0 | Jul 29, 2016, 04:49 PM |
| Pomerantz Roger | President and CEO | Jul 27, 2016 | Option Exercise | $0.71 | 20,000 | 14,200 | 203,692 | Jul 28, 2016, 06:01 PM |
| Pomerantz Roger | President and CEO | Jul 27, 2016 | Sale | $35.00 | 20,000 | 700,000 | 183,692 | Jul 28, 2016, 06:01 PM |
| Trucksis Michele | Chief Medical Officer and EVP | Jul 27, 2016 | Option Exercise | $15.77 | 38,064 | 600,269 | 38,064 | Jul 28, 2016, 06:00 PM |
| Trucksis Michele | Chief Medical Officer and EVP | Jul 27, 2016 | Sale | $35.14 | 38,064 | 1,337,512 | 0 | Jul 28, 2016, 06:00 PM |
| Aunins John G. | Chief Technology Officer & EVP | Jul 22, 2016 | Option Exercise | $0.48 | 187,500 | 90,000 | 220,155 | Jul 26, 2016, 05:54 PM |
| Aunins John G. | Chief Technology Officer & EVP | Jul 25, 2016 | Sale | $34.18 | 9,390 | 320,950 | 210,765 | Jul 26, 2016, 05:54 PM |
| Pomerantz Roger | President and CEO | Jul 06, 2016 | Option Exercise | $0.71 | 35,435 | 25,159 | 219,127 | Jul 07, 2016, 05:27 PM |
| Pomerantz Roger | President and CEO | Jul 05, 2016 | Option Exercise | $0.71 | 52,776 | 37,471 | 236,468 | Jul 07, 2016, 05:27 PM |
| Pomerantz Roger | President and CEO | Jul 06, 2016 | Sale | $29.65 | 35,435 | 1,050,716 | 209,227 | Jul 07, 2016, 05:27 PM |
| Pomerantz Roger | President and CEO | Jul 05, 2016 | Sale | $29.31 | 52,776 | 1,546,758 | 186,597 | Jul 07, 2016, 05:27 PM |
| Pomerantz Roger | President and CEO | Jul 01, 2016 | Option Exercise | $0.71 | 56,789 | 40,320 | 240,481 | Jul 05, 2016, 05:30 PM |
| Pomerantz Roger | President and CEO | Jul 01, 2016 | Sale | $29.81 | 56,789 | 1,692,705 | 235,649 | Jul 05, 2016, 05:30 PM |
| Shaff Eric D. | CFO and EVP | Jun 30, 2016 | Option Exercise | $7.79 | 4,533 | 35,312 | 4,533 | Jun 30, 2016, 05:46 PM |
| Shaff Eric D. | CFO and EVP | Jun 30, 2016 | Sale | $29.54 | 4,533 | 133,905 | 0 | Jun 30, 2016, 05:46 PM |
| Aunins John G. | Chief Technology Officer & EVP | Jun 27, 2016 | Sale | $27.23 | 9,390 | 255,690 | 32,655 | Jun 29, 2016, 07:21 PM |
| Shaff Eric D. | CFO and EVP | Jun 27, 2016 | Option Exercise | $7.79 | 3,334 | 25,972 | 3,334 | Jun 29, 2016, 07:21 PM |
| Shaff Eric D. | CFO and EVP | Jun 28, 2016 | Option Exercise | $7.79 | 1,667 | 12,986 | 1,667 | Jun 29, 2016, 07:21 PM |
| Shaff Eric D. | CFO and EVP | Jun 28, 2016 | Sale | $28.85 | 1,667 | 48,093 | 0 | Jun 29, 2016, 07:21 PM |
| Shaff Eric D. | CFO and EVP | Jun 27, 2016 | Sale | $28.00 | 3,334 | 93,352 | 0 | Jun 29, 2016, 07:21 PM |
| Pomerantz Roger | President and CEO | Jun 02, 2016 | Option Exercise | $0.71 | 74,049 | 52,575 | 257,741 | Jun 06, 2016, 04:30 PM |
| Pomerantz Roger | President and CEO | Jun 02, 2016 | Sale | $32.52 | 74,049 | 2,407,916 | 251,158 | Jun 06, 2016, 04:30 PM |
| COOK DAVID N | Chief Scientific Officer & EVP | Jun 02, 2016 | Sale | $31.00 | 8,000 | 248,000 | 136,673 | Jun 06, 2016, 04:27 PM |
| COOK DAVID N | Chief Scientific Officer & EVP | Jun 01, 2016 | Sale | $29.43 | 16,000 | 470,880 | 144,673 | Jun 02, 2016, 09:38 PM |
| Pomerantz Roger | President and CEO | Jun 01, 2016 | Option Exercise | $0.71 | 70,951 | 50,375 | 254,643 | Jun 02, 2016, 09:37 PM |
| Pomerantz Roger | President and CEO | Jun 01, 2016 | Sale | $30.51 | 70,951 | 2,164,838 | 236,133 | Jun 02, 2016, 09:37 PM |
| Aunins John G. | Chief Technology Officer & EVP | May 31, 2016 | Sale | $30.05 | 14,015 | 421,088 | 42,695 | Jun 02, 2016, 09:34 PM |
| AFEYAN NOUBAR | Director | May 25, 2016 | Sale | $27.60 | 1,000,000 | 27,600,000 | 2,734,994 | May 27, 2016, 06:43 PM |
| Pomerantz Roger | President and CEO | May 24, 2016 | Option Exercise | $0.71 | 9,801 | 6,959 | 193,493 | May 25, 2016, 09:11 PM |
| Pomerantz Roger | President and CEO | May 24, 2016 | Sale | $30.00 | 9,801 | 294,030 | 183,692 | May 25, 2016, 09:11 PM |
| Pomerantz Roger | President and CEO | May 18, 2016 | Option Exercise | $0.71 | 160,965 | 114,285 | 183,692 | May 19, 2016, 04:41 PM |
| Pomerantz Roger | President and CEO | May 06, 2016 | Option Exercise | $0.71 | 8,507 | 6,040 | 31,234 | May 09, 2016, 09:31 PM |
| Pomerantz Roger | President and CEO | May 06, 2016 | Sale | $24.31 | 8,507 | 206,803 | 23,035 | May 09, 2016, 09:31 PM |
| Pomerantz Roger | President and CEO | May 05, 2016 | Option Exercise | $0.71 | 30,027 | 21,319 | 43,854 | May 06, 2016, 04:28 PM |
| Pomerantz Roger | President and CEO | May 04, 2016 | Option Exercise | $0.71 | 29,298 | 20,802 | 51,325 | May 06, 2016, 04:28 PM |
| Pomerantz Roger | President and CEO | May 05, 2016 | Sale | $25.73 | 30,027 | 772,742 | 22,727 | May 06, 2016, 04:28 PM |
| Pomerantz Roger | President and CEO | May 04, 2016 | Sale | $26.54 | 29,298 | 777,536 | 22,727 | May 06, 2016, 04:28 PM |
| Pomerantz Roger | President and CEO | May 03, 2016 | Option Exercise | $0.71 | 23,680 | 16,813 | 46,407 | May 04, 2016, 05:06 PM |
| Pomerantz Roger | President and CEO | May 02, 2016 | Option Exercise | $0.71 | 43,687 | 31,018 | 66,414 | May 04, 2016, 05:06 PM |
| Pomerantz Roger | President and CEO | May 02, 2016 | Sale | $29.07 | 43,687 | 1,270,018 | 30,976 | May 04, 2016, 05:06 PM |
| Pomerantz Roger | President and CEO | May 03, 2016 | Sale | $28.01 | 23,680 | 663,179 | 30,069 | May 04, 2016, 05:06 PM |
| Aunins John G. | Chief Technology Officer & EVP | Apr 25, 2016 | Sale | $31.94 | 18,640 | 595,362 | 56,060 | Apr 27, 2016, 04:44 PM |
| Pomerantz Roger | President and CEO | Apr 07, 2016 | Option Exercise | $0.67 | 9,212 | 6,147 | 31,939 | Apr 11, 2016, 05:47 PM |
| Pomerantz Roger | President and CEO | Apr 07, 2016 | Sale | $30.00 | 9,212 | 276,360 | 22,727 | Apr 11, 2016, 05:47 PM |
| COOK DAVID N | Chief Scientific Officer & EVP | Apr 07, 2016 | Sale | $31.00 | 8,000 | 248,000 | 160,673 | Apr 11, 2016, 05:47 PM |
| Shaff Eric D. | CFO and EVP | Apr 04, 2016 | Option Exercise | $7.79 | 6,568 | 51,165 | 6,568 | Apr 06, 2016, 05:44 PM |
| Shaff Eric D. | CFO and EVP | Apr 04, 2016 | Sale | $28.85 | 6,568 | 189,487 | 0 | Apr 06, 2016, 05:44 PM |
| Pomerantz Roger | President and CEO | Apr 04, 2016 | Option Exercise | $0.48 | 44,825 | 21,516 | 67,552 | Apr 05, 2016, 08:59 PM |
| Pomerantz Roger | President and CEO | Apr 01, 2016 | Option Exercise | $0.48 | 90,963 | 43,662 | 113,690 | Apr 05, 2016, 08:59 PM |
| Pomerantz Roger | President and CEO | Apr 04, 2016 | Sale | $28.92 | 44,825 | 1,296,493 | 52,349 | Apr 05, 2016, 08:59 PM |
| Pomerantz Roger | President and CEO | Apr 01, 2016 | Sale | $26.35 | 90,963 | 2,397,303 | 73,184 | Apr 05, 2016, 08:59 PM |
| COOK DAVID N | Chief Scientific Officer & EVP | Apr 04, 2016 | Sale | $28.00 | 8,000 | 224,000 | 168,673 | Apr 05, 2016, 08:58 PM |
| COOK DAVID N | Chief Scientific Officer & EVP | Apr 01, 2016 | Sale | $25.88 | 53,000 | 1,371,586 | 183,023 | Apr 05, 2016, 08:58 PM |
| Shaff Eric D. | CFO and EVP | Mar 31, 2016 | Option Exercise | $7.79 | 7,663 | 59,695 | 7,663 | Apr 04, 2016, 07:23 PM |
| Shaff Eric D. | CFO and EVP | Mar 31, 2016 | Sale | $26.30 | 7,663 | 201,569 | 6,568 | Apr 04, 2016, 07:23 PM |
| Aunins John G. | Chief Technology Officer & EVP | Mar 28, 2016 | Sale | $23.89 | 9,390 | 224,327 | 74,700 | Mar 29, 2016, 07:09 PM |
| Shaff Eric D. | CFO and EVP | Mar 28, 2016 | Option Exercise | $7.79 | 5,473 | 42,635 | 5,473 | Mar 29, 2016, 07:08 PM |
| Shaff Eric D. | CFO and EVP | Mar 28, 2016 | Sale | $24.07 | 5,473 | 131,735 | 0 | Mar 29, 2016, 07:08 PM |
| Nestle Health Science US Holdings, Inc. | 10% Owner | Jul 01, 2015 | Option Exercise | $18.00 | 1,333,333 | 23,999,994 | 6,888,888 | Jul 01, 2015, 12:49 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| DesRosier Thomas | Chief Legal Officer and EVP | 02/16/2024 | 4,254 |
| Shaff Eric D. | CEO and President | 02/16/2024 | 12,473 |
| Henn Matthew R. | See Remarks | 02/16/2024 | 4,504 |
| Young Teresa L. | See Remarks | 02/16/2024 | 3,644 |
| von Moltke Lisa | See Remarks | 02/16/2024 | 4,752 |
| Ege David S. | See Remarks | 02/16/2024 | 5,411 |
| Arkowitz David | Chief Financial Officer | 02/16/2024 | 4,254 |
| Cloghessy Paula | See Remarks | 10/30/2023 | 3,920 |
| Shaff Eric D. | CEO and President | 10/30/2023 | 11,545 |
| Young Teresa L. | See Remarks | 10/30/2023 | 3,924 |
| Arkowitz David | Chief Financial Officer | 10/30/2023 | 5,489 |
| DesRosier Thomas | Chief Legal Officer and EVP | 10/30/2023 | 5,611 |
| Ege David S. | See Remarks | 10/30/2023 | 5,489 |
| von Moltke Lisa | See Remarks | 10/30/2023 | 5,713 |
| Henn Matthew R. | See Remarks | 10/30/2023 | 5,246 |
| Ege David S. | See Remarks | 04/28/2023 | 36,527 |
| Ege David S. | See Remarks | 10/31/2022 | 39,745 |
| Nutritional Health LTP Fund General Partner LLC | 10% Owner | 07/05/2022 | 18,350,310 |
| Nutritional Health LTP Fund General Partner LLC | 10% Owner | 07/05/2022 | 9,175,156 |
| DesRosier Thomas | Chief Legal Officer and EVP | 07/05/2022 | 200,000 |
| Henn Matthew R. | See Remarks | 07/05/2022 | 150,000 |
| Cloghessy Paula | See Remarks | 07/05/2022 | 100,000 |
| Arkowitz David | Chief Financial Officer | 07/05/2022 | 200,000 |
| Kender Richard N | Director | 07/05/2022 | 200,000 |
| Ege David S. | See Remarks | 07/05/2022 | 100,000 |
| Dere Willard H | Director | 07/05/2022 | 100,000 |
| Shaff Eric D. | CEO and President | 07/05/2022 | 200,000 |
| Zausner Meryl | Director | 07/05/2022 | 100,000 |
| Biondi Paul | Director | 07/05/2022 | 150,000 |
| Henn Matthew R. | See Remarks | 12/01/2020 | 443,720 |
| Henn Matthew R. | See Remarks | 12/01/2020 | 2,482,309 |
| Chapman Marcus | See Remarks | 11/22/2019 | 13,297 |
| AFEYAN NOUBAR | Director | 06/18/2019 | 19,999,998 |
| DesRosier Thomas | Chief Legal Officer and EVP | 01/28/2019 | 31,478 |
| Shaff Eric D. | See Remarks | 01/28/2019 | 25,188 |
| Aunins John G. | Chief Technology Officer & EVP | 12/17/2018 | 91,313 |
| Aunins John G. | See Remarks | 11/15/2018 | 117,912 |
| Aunins John G. | See Remarks | 10/15/2018 | 84,800 |
| Aunins John G. | See Remarks | 08/15/2018 | 108,069 |
| Aunins John G. | See Remarks | 05/15/2018 | 115,400 |
| Aunins John G. | See Remarks | 09/17/2018 | 103,875 |
| Pomerantz Roger | President and CEO | 09/06/2018 | 27,235 |
| Pomerantz Roger | President and CEO | 09/05/2018 | 86,714 |
| Aunins John G. | Chief Technology Officer & EVP | 07/15/2018 | 115,726 |
| Pomerantz Roger | President and CEO | 07/11/2018 | 717 |
| Pomerantz Roger | President and CEO | 07/11/2018 | 9,099 |
| Pomerantz Roger | President and CEO | 07/10/2018 | 4,252 |
| Pomerantz Roger | President and CEO | 07/09/2018 | 7,797 |
| Pomerantz Roger | President and CEO | 07/06/2018 | 10,910 |
| Pomerantz Roger | President and CEO | 07/10/2018 | 54,208 |
| Pomerantz Roger | President and CEO | 07/09/2018 | 100,351 |
| Pomerantz Roger | President and CEO | 07/06/2018 | 140,507 |
| Pomerantz Roger | President and CEO | 06/29/2018 | 3,192 |
| Pomerantz Roger | President and CEO | 06/28/2018 | 15,308 |
| Pomerantz Roger | President and CEO | 06/29/2018 | 40,915 |
| Pomerantz Roger | President and CEO | 06/28/2018 | 197,375 |
| Pomerantz Roger | President and CEO | 06/26/2018 | 15,069 |
| Pomerantz Roger | President and CEO | 06/25/2018 | 11,564 |
| Pomerantz Roger | President and CEO | 06/27/2018 | 12,064 |
| Pomerantz Roger | President and CEO | 06/26/2018 | 195,133 |
| Pomerantz Roger | President and CEO | 06/25/2018 | 246,504 |
| Pomerantz Roger | President and CEO | 06/27/2018 | 153,408 |
| Pomerantz Roger | President and CEO | 06/22/2018 | 374,761 |
| Pomerantz Roger | President and CEO | 06/21/2018 | 172,094 |
| Pomerantz Roger | President and CEO | 06/20/2018 | 247,051 |
| Aunins John G. | Chief Technology Officer & EVP | 06/15/2018 | 122,325 |
| Pomerantz Roger | President and CEO | 05/09/2018 | 2,097 |
| Aunins John G. | Chief Technology Officer & EVP | 04/25/2018 | 108,266 |
| Aunins John G. | See Remarks | 01/26/2018 | 19,153 |
| Shaff Eric D. | See Remarks | 01/26/2018 | 30,636 |
| DesRosier Thomas | See Remarks | 01/26/2018 | 38,295 |
| Trucksis Michele | See Remarks | 01/26/2018 | 28,729 |
| COOK DAVID N | See Remarks | 01/26/2018 | 19,153 |
| Aunins John G. | See Remarks | 12/19/2017 | 16,457 |
| Pomerantz Roger | President and CEO | 01/24/2018 | 28,571 |
| Aunins John G. | Chief Technology Officer & EVP | 12/19/2017 | 16,457 |
| Pomerantz Roger | President and CEO | 07/18/2017 | 71,429 |
| Aunins John G. | Chief Technology Officer & EVP | 04/25/2016 | 595,362 |
| Aunins John G. | Chief Technology Officer & EVP | 08/29/2016 | 102,069 |
| Aunins John G. | Chief Technology Officer & EVP | 07/27/2016 | 323,750 |
| Trucksis Michele | Chief Medical Officer and EVP | 07/28/2016 | 65,540 |
| Trucksis Michele | Chief Medical Officer and EVP | 07/28/2016 | 146,207 |
| Pomerantz Roger | President and CEO | 07/27/2016 | 14,200 |
| Pomerantz Roger | President and CEO | 07/27/2016 | 700,000 |
| Trucksis Michele | Chief Medical Officer and EVP | 07/27/2016 | 600,269 |
| Trucksis Michele | Chief Medical Officer and EVP | 07/27/2016 | 1,337,512 |
| Aunins John G. | Chief Technology Officer & EVP | 07/22/2016 | 90,000 |
| Aunins John G. | Chief Technology Officer & EVP | 07/25/2016 | 320,950 |
| Pomerantz Roger | President and CEO | 07/06/2016 | 25,159 |
| Pomerantz Roger | President and CEO | 07/05/2016 | 37,471 |
| Pomerantz Roger | President and CEO | 07/06/2016 | 1,050,716 |
| Pomerantz Roger | President and CEO | 07/05/2016 | 1,546,758 |
| Pomerantz Roger | President and CEO | 07/01/2016 | 40,320 |
| Pomerantz Roger | President and CEO | 07/01/2016 | 1,692,705 |
| Shaff Eric D. | CFO and EVP | 06/30/2016 | 35,312 |
| Shaff Eric D. | CFO and EVP | 06/30/2016 | 133,905 |
| Aunins John G. | Chief Technology Officer & EVP | 06/27/2016 | 255,690 |
| Shaff Eric D. | CFO and EVP | 06/27/2016 | 25,972 |
| Shaff Eric D. | CFO and EVP | 06/28/2016 | 12,986 |
| Shaff Eric D. | CFO and EVP | 06/28/2016 | 48,093 |
| Shaff Eric D. | CFO and EVP | 06/27/2016 | 93,352 |
| Pomerantz Roger | President and CEO | 06/02/2016 | 52,575 |
| Pomerantz Roger | President and CEO | 06/02/2016 | 2,407,916 |
| COOK DAVID N | Chief Scientific Officer & EVP | 06/02/2016 | 248,000 |
| COOK DAVID N | Chief Scientific Officer & EVP | 06/01/2016 | 470,880 |
| Pomerantz Roger | President and CEO | 06/01/2016 | 50,375 |
| Pomerantz Roger | President and CEO | 06/01/2016 | 2,164,838 |
| Aunins John G. | Chief Technology Officer & EVP | 05/31/2016 | 421,088 |
| AFEYAN NOUBAR | Director | 05/25/2016 | 27,600,000 |
| Pomerantz Roger | President and CEO | 05/24/2016 | 6,959 |
| Pomerantz Roger | President and CEO | 05/24/2016 | 294,030 |
| Pomerantz Roger | President and CEO | 05/18/2016 | 114,285 |
| Pomerantz Roger | President and CEO | 05/06/2016 | 6,040 |
| Pomerantz Roger | President and CEO | 05/06/2016 | 206,803 |
| Pomerantz Roger | President and CEO | 05/05/2016 | 21,319 |
| Pomerantz Roger | President and CEO | 05/04/2016 | 20,802 |
| Pomerantz Roger | President and CEO | 05/05/2016 | 772,742 |
| Pomerantz Roger | President and CEO | 05/04/2016 | 777,536 |
| Pomerantz Roger | President and CEO | 05/03/2016 | 16,813 |
| Pomerantz Roger | President and CEO | 05/02/2016 | 31,018 |
| Pomerantz Roger | President and CEO | 05/02/2016 | 1,270,018 |
| Pomerantz Roger | President and CEO | 05/03/2016 | 663,179 |
| Aunins John G. | Chief Technology Officer & EVP | 04/25/2016 | 595,362 |
| Pomerantz Roger | President and CEO | 04/07/2016 | 6,147 |
| Pomerantz Roger | President and CEO | 04/07/2016 | 276,360 |
| COOK DAVID N | Chief Scientific Officer & EVP | 04/07/2016 | 248,000 |
| Shaff Eric D. | CFO and EVP | 04/04/2016 | 51,165 |
| Shaff Eric D. | CFO and EVP | 04/04/2016 | 189,487 |
| Pomerantz Roger | President and CEO | 04/04/2016 | 21,516 |
| Pomerantz Roger | President and CEO | 04/01/2016 | 43,662 |
| Pomerantz Roger | President and CEO | 04/04/2016 | 1,296,493 |
| Pomerantz Roger | President and CEO | 04/01/2016 | 2,397,303 |
| COOK DAVID N | Chief Scientific Officer & EVP | 04/04/2016 | 224,000 |
| COOK DAVID N | Chief Scientific Officer & EVP | 04/01/2016 | 1,371,586 |
| Shaff Eric D. | CFO and EVP | 03/31/2016 | 59,695 |
| Shaff Eric D. | CFO and EVP | 03/31/2016 | 201,569 |
| Aunins John G. | Chief Technology Officer & EVP | 03/28/2016 | 224,327 |
| Shaff Eric D. | CFO and EVP | 03/28/2016 | 42,635 |
| Shaff Eric D. | CFO and EVP | 03/28/2016 | 131,735 |
| Nestle Health Science US Holdings, Inc. | 10% Owner | 07/01/2015 | 23,999,994 |
Load More Insider Transactions
FUNDS WITH A POSITION IN SERES THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 6,825,399 | 0.00012% | -7% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 2,132,643 | 0.00015% | 1.84% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 817,000 | 0.00177% | Exited | Other |
| D. E. SHAW & CO., INC. | 486,353 | 0.00032% | 188.61% | Other |
| AQR CAPITAL MANAGEMENT LLC | 166,887 | 0.00022% | 503.31% | Other |
| TUDOR INVESTMENT CORP ET AL | 61,977 | 0.00031% | No change | Event Driven, Other |
| BALYASNY ASSET MANAGEMENT L.P. | 55,011 | 0.00014% | Exited | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR SERES THERAPEUTICS INC
STOCK BUYBACKS FOR SERES THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
12.28%
1Q
09/30/2023
13.88%
2Q
06/30/2023
12.52%
3Q
03/31/2023
16.08%
4Q
12/31/2022
16.73%
5Q
09/30/2022
19.24%
6Q
06/30/2022
58.37%
7Q
03/31/2022
58.52%
8Q
12/31/2021
59.04%
9Q
09/30/2021
53.87%
10Q
06/30/2021
59.40%
11Q
03/31/2021
59.63%
12Q
12/31/2020
59.82%
13Q
09/30/2020
74.91%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SERES THERAPEUTICS INC
LOADING...